Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
28 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsIpsen receives positive CHMP opinion for Cabometyx® (cabozantinib) for the second-line treatment of patients with hepatocellular carcinoma (HCC)
(WorldNews France)

 
 

21 september 2018 09:41:55

 
Ipsen receives positive CHMP opinion for Cabometyx® (cabozantinib) for the second-line treatment of patients with hepatocellular carcinoma (HCC)
(WorldNews France)
 
Paris, France, September 21st, 2018 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), provided a positive opinion for Cabometyx® (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma (HCC) in adults who have been previously treated with...


 
16 viewsCategory: General > Europe > France
 
Altamir to invest via the Apax France IX fund in the Italian company AEB Group, a worldwide leader in biotechnological ingredients for wine, food and beverage
(WorldNews France)
Over 100 new companies join Euronext´s Techshare programme, expanding to four new countries
(WorldNews France)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten